Having trouble accessing articles? Reset your cache.

Taxotere docetaxel regulatory update

FDA approved a one-vial formulation of cancer drug Taxotere docetaxel.

Read the full 107 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE